Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Drug-induced aseptic meningitis in a Ph + ALL patient with meningeal involvement

Anne-Lise Beaumont, Ludovic Suner

Blood (2020) 136 (4): 520.

https://doi.org/10.1182/blood.2019004195

Published: 2020

Journal Articles

Pretransplant Risk Factors for Calcineurin Inhibitor-Induced Encephalopathy and Limbic Encephalitis Following Allogeneic Hematopoietic Cell Transplantation

Nao Tanizawa, MD, Hideo Koh, MD PhD, Hiroshi Okamura, MD PhD, Koh Shiro, MD PhD, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Asao Hirose, MD PhD, Mika Nakamae, MD PhD, Yasuhiro Nakashima, MD PhD, Takahiko Nakane, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2019) 134 (Supplement_1): 4492.

https://doi.org/10.1182/blood-2019-124264

Published: 2019

Journal Articles

High Complete Response Rates with Pembrolizumab in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma: Results of an Open-Label, Phase II Study

Loretta Nastoupil, MD, Jason R. Westin, MD, Nathan H. Fowler, MD, Michelle A. Fanale, MD, Felipe Samaniego, MD, Yasuhiro Oki, MD, Ly Dsouza, PA-C, Chizobam Obi, RN, JingJing Cao, Xiaoyun Cheng, Man Chun John MA, PhD, Wang Zhiqiang, Lei Feng, MS, Shouhao Zhou, R. Eric Davis, MD, Sattva S. Neelapu, MD

Blood (2017) 130 (Supplement 1): 414.

https://doi.org/10.1182/blood.V130.Suppl_1.414.414

Published: 2017

Journal Articles

A Retrospective Multicenter Analysis of the Safety and Efficacy of Brentuximab Vedotin (BV) As Monotherapy or in Combination with Bendamustine (BV-B) in Relapsed Refractory Classic Hodgkin Lymphoma (cHL) in Argentina

Florencia Negri Aranguren, MD, Santiago Cranco, Claudia Shanley, MD, Isolda I. Fernandez, MD, Maria Virginia Prates, MD, Victoria Otero, Lorena Fiad, Maria Cecilia Foncuberta, MD, Marcela Miodosky, MD, Miguel A. Pavlovsky, MD, Gustavo Kuminsky, Javier Bordone, Bruno Wannesson, Ariel Corso Corso, Dardo Riveros, MD, Marisa Marquez, MD, Gustavo Jarchum, MD, Maria Sol Jarchum, Ider Ramon Cerutti, MD, Alicia Bistmas, Monica Tamashiro, MD, Giselda De Stefano, Alicia Navieckas, Silvana Cugliari, MD, Pedro Negri Aranguren, MD, Gabriela Balaguer, Maria Tosin, Guillermina Remaggi, Juan Altuve, Juan Jose Garcia, MD, Luciana C. Ferrari, MD, Graciela Klein, Luciana Guanchiale, Luis Beligoy, MD, Mariana Marull, Maria Cecilia Dacunto, Marta Elisa Zerga, MD, Nicolas Matias Kurgansky, MD, Marcelo Pujol, MD, Rossana L. Taus, MD PhD, Federico Sackman, MD PhD, Veronica Cintia Canosa, Soledad Cruset, Maximiliano Riddick, Astrid Pavlovsky, MD

Blood (2017) 130 (Supplement 1): 4089.

https://doi.org/10.1182/blood.V130.Suppl_1.4089.4089

Published: 2017

Journal Articles

Paroxysmal Nocturnal Hemoglobinuria Caused By Pigt Mutations; Atypical PNH

Yoshiko Murakami, MDPhD, Michi Kawamoto, MD, Norimitsu Inoue, MD PhD, Makiko Osato, DS, Shogo Murata, MD PhD, Sho Murase, MD, Hajime Yoshimura, MD, Yasutaka Ueda, MD PhD, Jun-Ichi Nishimura, MD PhD, Yuzuru Kanakura, MD PhD, Nobuo Kohara, MD, Taroh Kinoshita, PhD

Blood (2016) 128 (22): 2450.

https://doi.org/10.1182/blood.V128.22.2450.2450

Published: 2016

Journal Articles

Immune Hemolysis and Aseptic Meningitis after Intravenous Immunoglobulin

Arun Kumar Arumugam Raajasekar, MBBS, Srikant Nannapaneni, MD MS, William B. Solomon, MD

Blood (2015) 126 (23): 4749.

https://doi.org/10.1182/blood.V126.23.4749.4749

Published: 2015

Journal Articles

Incidence and Natural History of Ivig-Induced Aseptic Meningitis: A Retrospective Review at a Single Tertiary Care Centre

Vighnesh Bharath, MDBSc, Kathleen Eckert, Matthew Kang, BHSc, MD FRCPC, Ian Chin-Yee, MD, Cyrus C. Hsia, BSc, MD FRCPC

Blood (2014) 124 (21): 2884.

https://doi.org/10.1182/blood.V124.21.2884.2884

Published: 2014

Journal Articles

Phase I Trial of Prophylactic Rituximab for the Prevention of Post Transplant Epstein-Barr Related Lymphoproliferative Disease (EBV-PTLD) Following T Cell Depleted (TCD) Unrelated or HLA-Mismatched Related Hematopoietic Cell Transplantation (HCT): Efficacy, Toxicity, and Effect on Subsequent B Cell Reconstitution

Trudy N Small, MD, Nancy A. Kernan, MD, Ann A. Jakubowski, MD, PhD, Molly A Knowles, BA, James W Young, MD, Hugo Castro-Malaspina, MD, Susan E Prockop, MD, Richard J. O'Reilly, MD, Esperanza B Papadopoulos, MD

Blood (2011) 118 (21): 1971.

https://doi.org/10.1182/blood.V118.21.1971.1971

Published: 2011

Journal Articles

HLH (Hemophagocytic Lymphohistiocytosis) At a Tertiary Care Hospital, B J Wadia Hospital for Children,In Mumbai, India

Mukesh Manharlal Desai, MBBS, MD, Harvinder Iqbal Palaha, MBBS, MD, Snehal Desai, MBBS, MD, Manisha Madkaikar, MBBS, MD, Bharat Agarwal, MBBS, MD, Nitin Shah, MBBS, MD, Archana Swami, MD, MBBS, MRCP, Kanjaksha Ghosh

Blood (2011) 118 (21): 4936.

https://doi.org/10.1182/blood.V118.21.4936.4936

Published: 2011

Journal Articles

Efficacy and Safety of Rituximab in Common Variable Immunodeficiency-Associated Immune Cytopenias: a Retrospective Analysis of 10 Cases.

Delphine Gobert, Lionel Galicier, Alice Berezne, Christophe Auzary, Thierry de Revel, Felipe Suarez, MD, PhD, Bernard Bonnotte, Roland Jaussaud, Marc Ruivard, Bertrand Godeau, Olivier Hermine, Marc Michel

Blood (2009) 114 (22): 1310.

https://doi.org/10.1182/blood.V114.22.1310.1310

Published: 2009

Journal Articles

Efficacy and Safety of a New Intravenous Immunoglobulin Product in Patients with Chronic Immune Thrombocytopenic Purpura.

Tadeusz Robak, Abdulgabar Salama, Lidia Kovaleva, Yaroslava I. Vyhovska, Simon Davies, Maria G. Mazzucconi, Othmar Zenker

Blood (2007) 110 (11): 1307.

https://doi.org/10.1182/blood.V110.11.1307.1307

Published: 2007

Journal Articles

Results of a Phase I Trial of SGN-40 (Anti-huCD40 mAb) in Patients with Relapsed Multiple Myeloma.

Mohamad A. Hussein, MD, James R. Berenson, MD, Ruben Niesvizky, MD, Nikhil C. Munshi, MD, Jeffrey Matous, MD, Kate Harrop, BA, Jonathan G. Drachman, MD

Blood (2006) 108 (11): 3576.

https://doi.org/10.1182/blood.V108.11.3576.3576

Published: 2006

Journal Articles

A Phase I Humanized Anti-CD40 Monoclonal Antibody (SGN-40) in Patients with Multiple Myeloma.

Mohamad A. Hussein, MD, James R. Berenson, MD, Ruben Niesvizky, MD, Nikhil C. Munshi, MD, Kate L. Harrop, Michael McDonald, MRCP, Jonathan G. Drachman, MD

Blood (2005) 106 (11): 2572.

https://doi.org/10.1182/blood.V106.11.2572.2572

Published: 2005

Journal Articles

Preparing Citrated Non-Activated Gamma Globulin for Rapid Infusion.

Edward Shanbrom, MD, William J. Owens, BS

Blood (2004) 104 (11): 4118.

https://doi.org/10.1182/blood.V104.11.4118.4118

Published: 2004

NARROW

Drug-induced aseptic meningitis in a Ph + ALL patient with meningeal involvement

Pretransplant Risk Factors for Calcineurin Inhibitor-Induced Encephalopathy and Limbic Encephalitis Following Allogeneic Hematopoietic Cell Transplantation

High Complete Response Rates with Pembrolizumab in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma: Results of an Open-Label, Phase II Study

A Retrospective Multicenter Analysis of the Safety and Efficacy of Brentuximab Vedotin (BV) As Monotherapy or in Combination with Bendamustine (BV-B) in Relapsed Refractory Classic Hodgkin Lymphoma (cHL) in Argentina

Paroxysmal Nocturnal Hemoglobinuria Caused By Pigt Mutations; Atypical PNH

Immune Hemolysis and Aseptic Meningitis after Intravenous Immunoglobulin

Incidence and Natural History of Ivig-Induced Aseptic Meningitis: A Retrospective Review at a Single Tertiary Care Centre

HLH (Hemophagocytic Lymphohistiocytosis) At a Tertiary Care Hospital, B J Wadia Hospital for Children,In Mumbai, India

Efficacy and Safety of Rituximab in Common Variable Immunodeficiency-Associated Immune Cytopenias: a Retrospective Analysis of 10 Cases.

Efficacy and Safety of a New Intravenous Immunoglobulin Product in Patients with Chronic Immune Thrombocytopenic Purpura.

Results of a Phase I Trial of SGN-40 (Anti-huCD40 mAb) in Patients with Relapsed Multiple Myeloma.

A Phase I Humanized Anti-CD40 Monoclonal Antibody (SGN-40) in Patients with Multiple Myeloma.

Preparing Citrated Non-Activated Gamma Globulin for Rapid Infusion.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only